Biotechnology (25) | Equity Distribution Agreements (25)

Browse by Company

Alector, Inc. (1)
Altimmune, Inc. (2)
Aptevo Therapeutics Inc. (1)
Aptose Biosciences Inc. (2)
Aravive, Inc. (1)
ATOSSA GENETICS INC (2)
Biohaven Pharmaceutical Holding Co Ltd. (1)
Cellectar Biosciences, Inc. (1)
HEMISPHERX BIOPHARMA INC (1)
iBio, Inc. (2)
Isoray, Inc. (1)
Millendo Therapeutics, Inc. (1)
OncoCyte Corp (1)
PALATIN TECHNOLOGIES INC (1)
SELLAS Life Sciences Group, Inc. (1)
Sorrento Therapeutics, Inc. (1)
Stellar Biotechnologies, Inc. (1)
T2 Biosystems, Inc. (3)
XBiotech Inc. (1)

Recent Contracts

Equity Distribution Agreement, dated February 25, 2021, by and among Altimmune, Inc. and Piper Sandler & Co., Evercore Group L.L.C. and B. Riley Securities, Inc (Altimmune, Inc., Filed With SEC on February 25, 2021)
Equity Distribution Agreement, dated as of December 23, 2020, by and between Biohaven Pharmaceutical Holding Company Ltd. and Goldman Sachs & Co. LLC, Piper Sandler & Co., SVB... (Biohaven Pharmaceutical Holding Co Ltd., Filed With SEC on December 23, 2020)
Equity Distribution Agreement, dated December 14, 2020, between Aptevo Therapeutics Inc. and Piper Sandler & Co (Aptevo Therapeutics Inc., Filed With SEC on December 14, 2020)
Equity Distribution Agreement, dated as of September 28, 2020, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Stellar Biotechnologies, Inc., Filed With SEC on September 28, 2020)
Equity Distribution Agreement, dated as of September 25, 2020, by and between Atossa Therapeutics, Inc. and Maxim Group LLC (ATOSSA GENETICS INC, Filed With SEC on September 25, 2020)
Equity Distribution Agreement between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc., dated August 11, 2020 (Cellectar Biosciences, Inc., Filed With SEC on August 11, 2020)
Amendment No. 1 to Equity Distribution Agreement, dated July 29, 2020, by and between iBio, Inc. and UBS Securities LLC (iBio, Inc., Filed With SEC on July 29, 2020)
Equity Distribution Agreement, dated June 17 2020, by and between iBio, Inc. and UBS Securities, LLC (iBio, Inc., Filed With SEC on June 17, 2020)
Equity Distribution Agreement, dated May 13, 2020, by and among Alector, Inc., Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC (Alector, Inc., Filed With SEC on May 13, 2020)
Equity Distribution Agreement, dated May 5, 2020, among Aptose Biosciences Inc., Piper Sandler & Co. and Canaccord Genuity LLC (Aptose Biosciences Inc., Filed With SEC on May 5, 2020)